25 related articles for article (PubMed ID: 10800755)
21. Neurochemical effects of 8-hydroxy-2-di-n-propylamino tetralin in rats treated with haloperidol.
Shireen E; Qurrat-ul-Ain ; Batool F; Saify ZS; Haleem DJ
Pak J Pharm Sci; 2002 Jan; 15(1):71-82. PubMed ID: 16414870
[TBL] [Abstract][Full Text] [Related]
22. Effects of intrastriatal infusion of D2 and D3 dopamine receptor preferring antagonists on dopamine release in rat dorsal striatum (in vivo microdialysis study).
Sotnikova TD; Gainetdinov RR; Grekhova TV; Rayevsky KS
Pharmacol Res; 2001 Mar; 43(3):283-90. PubMed ID: 11401421
[TBL] [Abstract][Full Text] [Related]
23. In vivo effects of the putative cognitive enhancer KA-672.HCl in comparison with 8-hydroxy-2-(di-N-propylamino) tetralin and haloperidol on dopamine, 3,4-dihydroxyphenylacetic acid, serotonin and 5-hydroxyindoleacetic acid levels in striatal and cortical brain regions.
Teismann P; Ferger B
Prog Neuropsychopharmacol Biol Psychiatry; 2000 Feb; 24(2):337-48. PubMed ID: 10800755
[TBL] [Abstract][Full Text] [Related]
24. Ensaculin (KA-672 HCl): a multitransmitter approach to dementia treatment.
Hoerr R; Noeldner M
CNS Drug Rev; 2002; 8(2):143-58. PubMed ID: 12177685
[TBL] [Abstract][Full Text] [Related]
25.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
